GlaxoSmithKline Q2 Profit Rises 16% to Rs 252 cr

By By Rediff Money Desk, New Delhi
Oct 29, 2024 16:52
GlaxoSmithKline Pharmaceuticals reports a 16% jump in Q2 net profit to Rs 252 crore, driven by strong sales across segments. Key brands like Augmentin and Nucala saw growth.
New Delhi, Oct 29 (PTI) GlaxoSmithKline Pharmaceuticals on Tuesday reported a 16 per cent year-on-year increase in its consolidated net profit to Rs 252 crore in the September quarter, aided by robust sales across segments.

The drug maker posted a net profit of Rs 217 crore for the July-September quarter of last fiscal.

Revenue from operations rose to Rs 1,010 crore for the September quarter compared with Rs 957 crore in the year-ago period, GlaxoSmithKline Pharmaceuticals said in a regulatory filing.

The company said its board declared a special interim dividend of Rs 12 per equity share of face value of Rs 10 each.

"As we mark our centenary year in India, we are happy to announce a special interim dividend to our shareholders. Our performance reflects our commitment to sustainable growth and innovation," GlaxoSmithKline Pharmaceuticals MD Bhushan Akshikar said.

The drugmaker said its key brands held their market share and continued to stay in line with the respective category performance.

Augmentin continues to be the leading brand in the overall Indian pharma market and the respiratory portfolio led by Nucala and Trelegy continued to gain market share, it said.

The pediatric vaccine portfolio delivered double-digit growth and maintained its market leadership in the private market, the drugmaker said.

In the adult vaccines segment, GSK continues to build on the momentum of its Shingrix Herpes Zoster Vaccine (recombinant, adjuvanted), advancing the adult immunisation category in India through innovative go-to-market (GTM) strategies, it added.

Shares of GSK Pharma ended 0.68 per cent down at Rs 2,624.50 apiece on BSE.
Source: PTI
Read More On:
net profitpharmaceuticalsq2 resultsglaxosmithklinegsk pharmaceuticals
DISCLAIMER - This article is from a syndicated feed. The original source is responsible for accuracy, views & content ownership. Views expressed may not reflect those of rediff.com India Limited.

You May Like To Read

MORE NEWS

Gold Price Soars on Dhanteras: Hits Rs 81,400

Gold prices surged to Rs 81,400 per 10 grams on Dhanteras due to strong demand. Silver...

ASK Automotive Q2 Net Profit Up 63% to Rs 67 Crore

ASK Automotive, India's largest brake shoe manufacturer, reported a 63% rise in net...

SBI Card Q2 Profit Down 33% to Rs 404 Cr

SBI Card's net profit fell 33% to Rs 404 crore in Q2 FY24 due to rising delinquency....

Virgin Atlantic Doubles London-Mumbai Flights

Virgin Atlantic launches its second daily flight from London Heathrow to Mumbai,...

Anant Raj Q2 Profit Surges 76% to Rs 105.58 Cr,...

Anant Raj Ltd.'s Q2 profit jumped 76% to Rs 105.58 crore. The company plans to raise up...

GlaxoSmithKline Q2 Profit Rises 16% to Rs 252 cr

GlaxoSmithKline Pharmaceuticals reports a 16% jump in Q2 net profit to Rs 252 crore,...

Karnataka CM Warns Officials on Tax Collection...

Karnataka Chief Minister Siddaramaiah has warned officials of accountability if they...

Domestic Base Metal Cos to Thrive in FY'25: ICRA

Robust prices and resilient domestic demand are set to drive the performance of...

Transformers and Rectifiers (India) Wins Rs 270...

Transformers and Rectifiers (India) secures orders worth Rs 270 crore from Adani...

HUDCO Q2 Profit Surges 52% to Rs 689 cr

HUDCO's consolidated net profit for Q2 FY24 jumped 52% to Rs 689 cr, driven by...

Read More »

Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2024 Rediff.com